MON-LB102 Metformin-Induced Weight Loss in Patients With or Without Type 2 Diabetes/Prediabetes

Background: Metformin is the first-line pharmacologic treatment for type 2 diabetes (T2DM). Its use has been associated with significant weight loss in patients with obesity with or without T2DM. However, it is unknown whether weight loss outcomes differ with metformin monotherapy in patients with e...

Descripción completa

Detalles Bibliográficos
Autores principales: Chukir, Tariq, Mandel, Lindsay, Al-Mulla, Nada, Kumar, Rekha Babu, Igel, Leon I, Waitman, Jonathan, Aronne, Louis J, Shukla, Alpana P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Adipose Tissue, Appetite, and Obesity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208508/
http://dx.doi.org/10.1210/jendso/bvaa046.2084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208508/
http://dx.doi.org/10.1210/jendso/bvaa046.2084

Ejemplares similares